CL2009001025A1 - Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. - Google Patents
Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.Info
- Publication number
- CL2009001025A1 CL2009001025A1 CL2009001025A CL2009001025A CL2009001025A1 CL 2009001025 A1 CL2009001025 A1 CL 2009001025A1 CL 2009001025 A CL2009001025 A CL 2009001025A CL 2009001025 A CL2009001025 A CL 2009001025A CL 2009001025 A1 CL2009001025 A1 CL 2009001025A1
- Authority
- CL
- Chile
- Prior art keywords
- buffering agent
- alkaline buffering
- filler
- useful
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
Composición de pastilla oral para chupar que comprende a) un componente de gránulo patrón comprendiendo al menos un agente tampón alcalino, al menos un modificador de la disolución y al menos una carga; b) un principio activo de nicotina y al menos un agente tampón alcalino; útil para eliminar o reducir el uso del tabaco.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4951508P | 2008-05-01 | 2008-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2009001025A1 true CL2009001025A1 (es) | 2010-09-24 |
Family
ID=41255405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2009001025A CL2009001025A1 (es) | 2008-05-01 | 2009-04-29 | Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. |
Country Status (19)
Country | Link |
---|---|
US (3) | US8501164B2 (es) |
EP (1) | EP2285411B1 (es) |
JP (2) | JP5893405B2 (es) |
CN (1) | CN102076362B (es) |
AR (1) | AR071420A1 (es) |
AU (1) | AU2009243065B2 (es) |
BR (1) | BRPI0911847B8 (es) |
CA (1) | CA2723011A1 (es) |
CL (1) | CL2009001025A1 (es) |
DK (1) | DK2285411T3 (es) |
ES (1) | ES2605244T3 (es) |
HK (1) | HK1153146A1 (es) |
HU (1) | HUE031175T2 (es) |
MX (1) | MX2010011929A (es) |
MY (1) | MY164646A (es) |
PL (1) | PL2285411T3 (es) |
PT (1) | PT2285411T (es) |
RU (1) | RU2458692C2 (es) |
WO (1) | WO2009134947A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5845194B2 (ja) | 2010-02-18 | 2016-01-20 | サッカー・ジャティン・ヴァサントTHAKKAR, Jatin Vasant | ニコチン含有ソフトゼラチントローチ |
UA112974C2 (uk) | 2010-09-16 | 2016-11-25 | Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид | Нікотиновмісна композиція (варіанти) |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
AR096223A1 (es) * | 2013-05-10 | 2015-12-16 | Glaxosmithkline Llc | Pastilla de nicotina para administración oral |
DK3052081T3 (da) * | 2013-10-03 | 2021-01-18 | Altria Client Services Llc | Pastil |
US9351936B2 (en) | 2013-10-03 | 2016-05-31 | Altria Client Services Llc | Nicotine lozenge |
US10105320B2 (en) | 2013-10-03 | 2018-10-23 | Altria Client Services | Soluble fiber lozenge |
US11779045B2 (en) | 2013-10-03 | 2023-10-10 | Altria Client Services Llc | Dissolvable-chewable exhausted-tobacco tablet |
US10244786B2 (en) | 2013-10-03 | 2019-04-02 | Altria Client Services Llc | Tobacco lozenge |
US9999243B2 (en) * | 2013-10-03 | 2018-06-19 | Altria Client Services Llc | Exhausted tobacco lozenge |
US20170172995A1 (en) * | 2015-09-08 | 2017-06-22 | Venkateswara Rao Repaka | Pharmaceutical compositions of Nicotine and process for preparation thereof |
US11311623B2 (en) | 2016-04-21 | 2022-04-26 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
US20210345656A1 (en) * | 2017-12-08 | 2021-11-11 | Fertin Pharma A/S | High nicotine absorption |
BR112020011238A2 (pt) * | 2017-12-08 | 2021-01-05 | Fertin Pharma A/S | Formulação de nicotina oral sólida para alívio de desejo de nicotina de início rápido, formulação de nicotina oral sólida para uso na atenuação do desejo de nicotina, método de atenuação do desejo de nicotina e bolsa oral |
EP3720497A1 (en) * | 2017-12-08 | 2020-10-14 | Fertin Pharma A/S | High nicotine concentration |
CN111447921B (zh) * | 2017-12-08 | 2023-10-13 | 费尔廷制药公司 | 烟碱片剂 |
CA3040547C (en) | 2019-04-17 | 2021-12-07 | Medcan Pharma A/S | Cannabinoid lozenge formulation |
US11759419B2 (en) * | 2019-10-11 | 2023-09-19 | Fertin Pharma A/S | Compressed nicotine lozenge |
US11000540B1 (en) * | 2019-11-22 | 2021-05-11 | Al Siamon | Treatment for reducing adverse events including chemotherapy discomfort and other conditions |
US20220387328A1 (en) * | 2021-06-04 | 2022-12-08 | Glaxosmithkline Consumer Healthcare Holdings (Us) Llc | Dosage form for nicotine replacement therapy |
WO2023053060A1 (en) * | 2021-09-30 | 2023-04-06 | Nicoventures Trading Limited | Oral gum composition |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863737A (en) | 1985-05-01 | 1989-09-05 | University Of Utah | Compositions and methods of manufacture of compressed powder medicaments |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
US5135753A (en) | 1991-03-12 | 1992-08-04 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
US5549906A (en) | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
PL187242B1 (pl) | 1996-05-13 | 2004-06-30 | Novartis Consumer Health Sa | Policzkowy układ dostarczający |
ES2336054T3 (es) | 1998-12-18 | 2010-04-07 | Alza Corporation | Dispositivo transparente para la administracion transdermica de nicotina. |
FR2792200B3 (fr) * | 1999-04-16 | 2001-06-08 | Unicliffe Ltd | Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer |
NZ530439A (en) * | 2001-04-20 | 2004-11-26 | Lavipharm Lab Inc | Intraoral delivery of nicotine for smoking cessation |
SE0102197D0 (sv) | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
WO2003053402A1 (en) | 2001-12-20 | 2003-07-03 | Pharmacia Corporation | Zero-order sustained released dosage forms and method of making the same |
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
US20040052851A1 (en) * | 2002-09-16 | 2004-03-18 | Graff Allan H. | Modified release oral dosage form |
DK1803444T3 (en) * | 2002-12-20 | 2019-02-25 | Niconovum Ab | PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC) |
US20040182403A1 (en) | 2003-02-28 | 2004-09-23 | Sven-Borje Andersson | Container comprising nicotine and the use and manufacture thereof |
GB0320854D0 (en) * | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
DE602004019430D1 (de) | 2003-09-08 | 2009-03-26 | Mcneil Ab | Nikotinformulierungen und ihre verwendung |
US20050123502A1 (en) * | 2003-10-07 | 2005-06-09 | Chan Shing Y. | Nicotine containing oral compositions |
US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
EP1998754A2 (en) | 2006-03-16 | 2008-12-10 | NicoNovum AB | Stable lozenge compositions providing rapid release of nicotine |
US20070269386A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
US20080286341A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
US20080287507A1 (en) | 2007-05-16 | 2008-11-20 | John Hedenstrom | Nicotine containing toiletry waters |
US20080286340A1 (en) | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
US20090004248A1 (en) | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
US20090164008A1 (en) * | 2007-12-21 | 2009-06-25 | Xin Hong | Lens surface with combined diffractive, toric, and aspheric components |
PT2361081T (pt) | 2008-10-14 | 2016-09-05 | Mcneil Ab | Forma de dosagem intra-oral multiporção e seu uso |
EP2233134A1 (en) | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
US8784781B2 (en) | 2009-09-24 | 2014-07-22 | Mcneil-Ppc, Inc. | Manufacture of chewing gum product with radiofrequency |
-
2009
- 2009-04-29 CL CL2009001025A patent/CL2009001025A1/es unknown
- 2009-04-29 AR ARP090101535 patent/AR071420A1/es not_active Application Discontinuation
- 2009-04-30 DK DK09739749.1T patent/DK2285411T3/da active
- 2009-04-30 PL PL09739749T patent/PL2285411T3/pl unknown
- 2009-04-30 ES ES09739749.1T patent/ES2605244T3/es active Active
- 2009-04-30 EP EP09739749.1A patent/EP2285411B1/en active Active
- 2009-04-30 MY MYPI2010005122A patent/MY164646A/en unknown
- 2009-04-30 US US12/990,049 patent/US8501164B2/en active Active
- 2009-04-30 BR BRPI0911847A patent/BRPI0911847B8/pt active IP Right Grant
- 2009-04-30 RU RU2010149050/15A patent/RU2458692C2/ru active
- 2009-04-30 WO PCT/US2009/042190 patent/WO2009134947A1/en active Application Filing
- 2009-04-30 HU HUE09739749A patent/HUE031175T2/en unknown
- 2009-04-30 CN CN200980125040.6A patent/CN102076362B/zh active Active
- 2009-04-30 MX MX2010011929A patent/MX2010011929A/es active IP Right Grant
- 2009-04-30 JP JP2011507628A patent/JP5893405B2/ja active Active
- 2009-04-30 PT PT97397491T patent/PT2285411T/pt unknown
- 2009-04-30 CA CA 2723011 patent/CA2723011A1/en not_active Abandoned
- 2009-04-30 AU AU2009243065A patent/AU2009243065B2/en active Active
-
2011
- 2011-07-15 HK HK11107381.9A patent/HK1153146A1/zh unknown
-
2013
- 2013-06-26 US US13/927,163 patent/US8940772B2/en active Active
-
2014
- 2014-12-17 US US14/572,953 patent/US20150105431A1/en not_active Abandoned
-
2015
- 2015-07-27 JP JP2015147991A patent/JP6159761B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
BRPI0911847B8 (pt) | 2021-05-25 |
HUE031175T2 (en) | 2017-06-28 |
US20110110880A1 (en) | 2011-05-12 |
EP2285411B1 (en) | 2016-09-21 |
US20130289079A1 (en) | 2013-10-31 |
BRPI0911847A2 (pt) | 2015-10-06 |
PT2285411T (pt) | 2016-11-25 |
PL2285411T3 (pl) | 2017-07-31 |
HK1153146A1 (zh) | 2012-03-23 |
MY164646A (en) | 2018-01-30 |
DK2285411T3 (da) | 2017-01-02 |
BRPI0911847B1 (pt) | 2021-04-13 |
AU2009243065B2 (en) | 2013-05-23 |
US8501164B2 (en) | 2013-08-06 |
JP5893405B2 (ja) | 2016-03-23 |
CA2723011A1 (en) | 2009-11-05 |
EP2285411A4 (en) | 2011-05-18 |
ES2605244T3 (es) | 2017-03-13 |
WO2009134947A1 (en) | 2009-11-05 |
JP2011519862A (ja) | 2011-07-14 |
AR071420A1 (es) | 2010-06-16 |
MX2010011929A (es) | 2010-11-30 |
US8940772B2 (en) | 2015-01-27 |
JP6159761B2 (ja) | 2017-07-05 |
BRPI0911847A8 (pt) | 2018-03-06 |
RU2458692C2 (ru) | 2012-08-20 |
EP2285411A1 (en) | 2011-02-23 |
CN102076362B (zh) | 2015-01-21 |
US20150105431A1 (en) | 2015-04-16 |
RU2010149050A (ru) | 2012-06-10 |
JP2015232012A (ja) | 2015-12-24 |
AU2009243065A1 (en) | 2009-11-05 |
CN102076362A (zh) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2009001025A1 (es) | Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco. | |
ECSP088240A (es) | Composición de trazodona para administración una vez por día | |
CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
CL2013001586A1 (es) | Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion. | |
ES2526606T3 (es) | Composición farmacéutica sólida que comprende amlodipina y losartán | |
CL2009001600A1 (es) | Composicion que comprende una fuente de dioxido de cloro, al menos 5 ppm de dioxido de cloro y no mas de 0,25 mg de aniones oxicloro por gramo de composiicon; util para aliviar infecciones de tejido en la cavidad oral. | |
BR112014019262A8 (pt) | Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas | |
CR9864A (es) | Formas de presentacion farmaceutica solidas de administracion oral con liberacion rapida de principio activo | |
CL2010001620A1 (es) | Composicion agricola, del cuidado personal, del cuidado de la casa y de revestimiento que comprende silicona y otro componente adicional; emulsion acuosa y no acuosa que comprende la composicion agricola; y metodo para formular dichas composiciones (div. sol. n° 656-207). | |
AR069875A1 (es) | Composiciones de temazepam para tabletas de desintegracion oral y metodo de preparacion | |
AR076153A1 (es) | Forma de dosificacion intra-oral de multiples porciones con propiedades organolepticas. formulaciones | |
CL2010001366A1 (es) | Composicion farmaceutica de liberacion controlada que comprende topiramato, celulosa microcristalina y metilcelulosa; preparado farmaceutico que la comprende, util para tratar la obesidad, diabetes o una afeccion relacionada. | |
CO6311067A2 (es) | Preparación de comprimido con liberación retardada que contiene polivinilpirrolidonas y principio activo | |
AR061772A1 (es) | Composicion de alto contenido de ion fluoruro para el cuidado oral y metodo para mantener la actividad anticaries | |
DOP2013000224A (es) | Uso de 2,3-dihidroimidazo[1,2-c] quinazolinas sustituidas. | |
BR112014005134A2 (pt) | composição farmacêutica de dissolução rápida | |
BRPI0607409A2 (pt) | preparação de retardo em forma de comprimidos contra vertigem | |
BR112012009857A2 (pt) | composições farmacêuticas sólidas contendo um inibidor de integrase | |
CL2007003587A1 (es) | Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c. | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
UY31780A (es) | Fenoxibenzamidas sustituidas | |
CO6270217A2 (es) | Formulaciones galenicas de alisquireno y valsartan | |
CR9259A (es) | Composicion antihelmintica | |
EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
PE20061390A1 (es) | Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la produccion de las mismas |